Related Experiment Videos
Kidney scintigraphy with 99mTc-DMSA and 131I-hippurate
Scandinavian Journal of Urology and Nephrology
|January 1, 1979
Summary
This study evaluates technetium-99m dimercaptosuccinylic acid (99mTc-DMSA) scintigraphy for diagnosing kidney abnormalities. While effective for detecting parenchymal disease, especially when imaging is challenging, it has limitations in functional assessment and diagnosing obstructive nephropathy.
Area of Science:
- Nuclear Medicine
- Radiology
- Nephrology
Background:
- Kidney abnormalities require accurate diagnostic tools for effective management.
- Scintigraphy offers a non-invasive method for evaluating renal morphology and function.
Purpose of the Study:
- To assess the utility of 99mTc-DMSA scintigraphy in diagnosing various kidney abnormalities.
- To propose a simplified scintigraphic protocol for routine use.
- To evaluate the complementary role of 131I-hippurate renography.
Main Methods:
- 43 patients with and without renal disease underwent extended 99mTc-DMSA scintigraphy.
- A simplified protocol involved scintiphotos at 10-15 min and 120 min post-injection.
- 131I-hippurate renography was performed subsequently.
Main Results:
- 99mTc-DMSA effectively identified diffuse parenchymal disease, particularly in cases of radiological non-visualization.
- The technique is valuable when iodine contrast media are contraindicated.
- Functional evaluation was limited in certain patient categories; obstructive nephropathy diagnosis required pelvic dilation.
- Differentiation between cysts (hypoperfused) and tumors (hyperperfused) was tentatively possible.
Conclusions:
- Simplified 99mTc-DMSA scintigraphy is valuable for detecting morphological kidney abnormalities, especially diffuse parenchymal disease.
- It serves as an alternative when contrast media cannot be used.
- Combined with 131I-hippurate renography, it provides comprehensive functional and morphological assessment.